Gene · 10544
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune evasion runs in the family: two surface protein families of Plasmodium falciparum-infected erythrocytes. | Curr Opin Microbiol | 2025 | 40112571 | PubTator, text mining | PubMed |
| γδ T cells as sensors of ectopically expressed intracellular proteins. | Cell Mol Immunol | 2025 | 40102685 | PubTator, text mining | PubMed |
| Heritable Genetic Variability in Ovarian Tumours: Exploring Venous Thromboembolism Susceptibility and Cancer Prognosis in a Hospital-Based Study. | Gene | 2025 | 40032058 | PubTator, text mining | PubMed |
| Identification of mouse and human embryonic pancreatic cells with adult Procr+ progenitor transcriptomic and epigenomic characteristics. | Front Endocrinol (Lausanne) | 2025 | 40017694 | PubTator, text mining | PubMed |
| Recombinant factor VIIa: new insights into the mechanism of action through product innovation. | Res Pract Thromb Haemost | 2025 | 39990097 | PubTator, text mining | PubMed |
| Plasma proteome variation and its genetic determinants in children and adolescents. | Nat Genet | 2025 | 39972214 | PubTator, text mining | PubMed |
| Tissue factor-dependent colitogenic CD4+ T cell thrombogenicity is regulated by activated protein C signalling. | Nat Commun | 2025 | 39956825 | PubTator, text mining | PubMed |
| Endothelial protein C receptor promotes retinal neovascularization through heme catabolism. | Nat Commun | 2025 | 39948347 | PubTator, text mining | PubMed |
| Identification of critical biomarkers and immune infiltration in preeclampsia through bioinformatics and machine learning methods. | BMC Pregnancy Childbirth | 2025 | 39934690 | PubTator, text mining | PubMed |
| Methodologic considerations on how to identify human hematopoietic stem cells. | Exp Hematol | 2025 | 39892848 | PubTator, text mining | PubMed |
| Endothelium Modulates the Prothrombotic Phenotype of Factor V Leiden: Evidence From an Ex Vivo Model. | Arterioscler Thromb Vasc Biol | 2025 | 39846164 | PubTator, text mining | PubMed |
| Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis. | Thromb Res | 2025 | 39793535 | PubTator, text mining | PubMed |
| Malaria monoclonals block brain binding. | Trends Parasitol | 2025 | 39755505 | PubTator, text mining | PubMed |
| Thrombomodulin: A key regulator of intravascular blood coagulation, fibrinolysis, and inflammation, and a treatment for disseminated intravascular coagulation. | Proc Jpn Acad Ser B Phys Biol Sci | 2025 | 39694492 | PubTator, text mining | PubMed |
| Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy. | Blood Vessel Thromb Hemost | 2024 | 40191177 | PubTator, text mining | PubMed |
| Islet organoids: a new hope for islet transplantation in diabetes. | Front Immunol | 2024 | 39906747 | PubTator, text mining | PubMed |
| Active withdrawal of corticosteroids using tocilizumab and its association with autoantibody profiles in relapsed Takayasu arteritis: a multicentre, single-arm, prospective study (the Ab-TAK study). | Front Immunol | 2024 | 39840060 | PubTator, text mining | PubMed |
| Corrigendum to 'Proteomic Profiling of CCCA Reveals Role of Humoral Immune Response Pathway and Metabolic Dysregulation' JID Innovations, Volume 4, Issue 3, May 2024, 100263. | JID Innov | 2024 | 39619251 | PubTator, text mining | PubMed |
| Recurrent Early Pregnancy Loss and Congenital Thrombophilia: A Prospective Study. | J Clin Med | 2024 | 39598015 | PubTator, text mining | PubMed |
| Broadly inhibitory antibodies to severe malaria virulence proteins. | Nature | 2024 | 39567685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10544/papers?page=5